Skip to main content
All lobbying filings

EXELIXIS INC.

Lobbying for EXELIXIS INC.

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $500,000.00 expenses · posted Jan 20, 2026

Official filing document

 Bills named in this filing 2
 Lobbying activity 2
Taxation/Internal Revenue Code

IRC Section 174 amortization of R&D expenditures.

Health Issues

Proposals related to drug pricing including the Administrations Most-Favored-Nation Prescription Drug Pricing proposal, implementation of drug-related provisions of the Inflation Reduction Act, and administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.1930/HR 3731, Small Biotech Innovation Act. Health agency funding levels.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem